Shares of Acasti Pharma Inc. (CVE:ACST – Get Rating) reached a new 52-week low on Friday . The company traded as low as C$1.03 and last traded at C$1.03, with a volume of 8313 shares. The stock had previously closed at C$1.03.
Acasti Pharma Trading Down 1.0 %
The firm has a market capitalization of C$45.50 million and a price-to-earnings ratio of -1.71. The business has a 50-day moving average of C$1.10 and a two-hundred day moving average of C$1.24. The company has a quick ratio of 10.62, a current ratio of 11.13 and a debt-to-equity ratio of 0.78.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.